Celcuity

Celcuity Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Celcuity (CELC) as of Nov 11, 2026 is -24,228.80. In the previous year, Days Inventory Outstanding (DIO) was -352.45 — a change of 6,774.42% (lower).

Days Inventory Outstanding

-24,228.80

YoY

6,774.42%

Last updated:

Days Inventory Outstanding (DIO) of Celcuity is 2024 -24,228.80 . Days Inventory Outstanding (DIO) of Celcuity was 2023 -352.45 . It decreases by 6,774.42% lower compared to the previous year.

The Celcuity Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2017
0.00 USD
Jan 1, 2019
-204.57 USD
Jan 1, 2020
-179.85 USD
Jan 1, 2021
-359.62 USD
Jan 1, 2022
-352.45 USD
Jan 1, 2024
-24,228.80 USD
The Celcuity Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
-24,228.80+6,774.42%
-352.45-1.99%
-359.62+99.95%
-179.85-12.08%
-204.57—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celcuity Stock analysis

What does Celcuity do? Celcuity Inc is a biotechnology company founded by Brian Sullivan in 2012. The company is headquartered in Minneapolis, USA. The business model of Celcuity is based on researching and developing new diagnostic and treatment methods for various types of cancer. The company utilizes a proprietary technology platform called CELx, which enables the analysis of cancer cell signaling pathways and the development of individualized treatment strategies. Celcuity specializes in the development of diagnostics and personalized therapies based on individual cancer cell signaling pathways. The company operates in two divisions: 1. Diagnostics division: Celcuity's diagnostics division focuses on identifying new cancer markers and biomarkers for early detection of cancer and the development of individualized treatment strategies. 2. Therapy division: Celcuity's therapy division specializes in the development of personalized therapies based on individual cancer cell signaling pathways. Celcuity currently offers two products based on the CELx technology platform: 1. CELx HUB: CELx HUB is a cloud-based software that allows doctors and researchers to analyze cancer samples and develop individualized treatment strategies. 2. CELx TIL: CELx TIL is a diagnostic tool that measures the presence of tumor cells in the immune system of cancer patients. In summary, Celcuity Inc is a leader in the field of personalized cancer therapy based on individual cancer cell signaling pathways. The company has found a niche in this growing market and has a unique technology platform that allows it to serve its customers effectively. With its products and services, Celcuity is helping to revolutionize cancer treatment and improve the quality of life for cancer patients worldwide. Celcuity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celcuity stock

Days Inventory Outstanding (DIO) of Celcuity is -24,228.80 in 2024.

Days Inventory Outstanding (DIO) of Celcuity changed from -352.45 to -24,228.80, representing a 6,774.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Celcuity since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Celcuity with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Celcuity

All Key Metrics — Celcuity